AMIX 10-Q: SEC filing
Autonomix Medical
Filed with the SEC on · accession 0001437749-26-036033
AMIX filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved +6.5% by the first close after the filing.
Summary of the filing
Autonomix Medical filed its quarterly 10-Q report for the period ended September 30, 2026, disclosing financial results including a net loss and details of its capital structure, warrants, and equity compensation.
Key details
How AMIX stock reacted
Close before
$1.70
Nov 9, 2026
First close after
+6.47%
$1.81
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for AMIX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AMIX?
Click hereFrequently asked questions
What did AMIX file with the SEC on Nov 10, 2026?
AMIX filed a 10-Q (SEC filing). Autonomix Medical filed its quarterly 10-Q report for the period ended September 30, 2026, disclosing financial results including a net loss and details of its capital structure, warrants, and equity compensation.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did AMIX stock react to this filing?
AMIX closed at $1.70 before the filing and $1.81 on Nov 10, 2026 (+6.47%).
Other AMIX SEC filings
Get alerts when AMIX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days